EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Signaling pathway mechanisms of neurological diseases induced by G protein‐coupled receptor 39

Bin Cao, Jue Wang, Juan Feng iD

CNS Neuroscience & Therapeutics · 2023

DOI: 10.1111/cns.14174 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, 2023. Verfasst von Bin Cao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Nervous System Diseases, Signal Transduction. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

G protein‐coupled receptor 39 (GPR39) is a transmembrane zinc receptor with two splice variants, which belongs to the G‐protein‐coupled receptor growth hormone‐releasing peptide family. Its expression is induced by zinc, which activates GPR39, and its activation mediates cell proliferation, ion homeostasis, and anti‐inflammatory, antioxidant, and other pathophysiological effects via different signaling pathways.

Aims

The article reviews the latest literature in this field. In particular, the role of GPR39 in nervous system is discussed. Materials and methods GPR39 can be a promising target in neurological diseases for targeted therapy, which will help doctors overcome the associated problems.

Discussion

GPR39 is expressed in vivo at several sites. Increasing evidence suggests that GPR39 plays an important role as a neuroprotective agent in vivo and regulates various neurological functions, including neurodegeneration, neuroelectrophysiology, and neurovascular homeostasis.

Conclusion

This review aims to provide an overview of the functions, signal transduction pathways, and pathophysiological role of GPR39 in neurological diseases and summarize the GPR39 agonists that have been identified in the recent years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nervous System DiseasesSignal TransductionHumansHomeostasisReceptors, G-Protein-CoupledZinc

Stichwörter der Autor:innen

GPR39GPR39 agonistGPR39 signalingzinc

Substanzen

GPR39 protein, humanReceptors, G-Protein-CoupledZinc

Autor:innen und Institutionen

  • Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, China.

ORCID-Profile: Juan Feng

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Cao, B., Wang, J., & Feng, J. (2023). Signaling pathway mechanisms of neurological diseases induced by G protein‐coupled receptor 39. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14174

Vancouver

Cao B, Wang J, Feng J. Signaling pathway mechanisms of neurological diseases induced by G protein‐coupled receptor 39. CNS Neuroscience & Therapeutics. 2023. doi:10.1111/cns.14174

BibTeX
@article{Cao2023,
  author = {Cao, Bin and Wang, Jue and Feng, Juan},
  title = {Signaling pathway mechanisms of neurological diseases induced by G protein‐coupled receptor 39},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2023},
  doi = {10.1111/cns.14174}
}
Kostenlos starten →